Peli1 Modulates the Subcellular Localization and Activity of Mdmx

Mdm2 and Mdmx, both major repressors of p53 in human cancers, are predominantly localized to the nucleus and cytoplasm, respectively. The mechanism by which subcellular localization of Mdmx is regulated remains unclear. In this study, we identify the E3 ligase Peli1 as a major binding partner and re...

Full description

Saved in:
Bibliographic Details
Published inCancer research (Chicago, Ill.) Vol. 78; no. 11; pp. 2897 - 2910
Main Authors Li, Dawei, Tavana, Omid, Sun, Shao-Cong, Gu, Wei
Format Journal Article
LanguageEnglish
Published United States American Association for Cancer Research, Inc 01.06.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Mdm2 and Mdmx, both major repressors of p53 in human cancers, are predominantly localized to the nucleus and cytoplasm, respectively. The mechanism by which subcellular localization of Mdmx is regulated remains unclear. In this study, we identify the E3 ligase Peli1 as a major binding partner and regulator of Mdmx in human cells. Peli1 bound Mdmx in vitro and in vivo and promoted high levels of ubiquitination of Mdmx. Peli1-mediated ubiquitination was degradation-independent, promoting cytoplasmic localization of Mdmx, which in turn resulted in p53 activation. Consistent with this, knockdown or knockout Peli1 in human cancer cells induced nuclear localization of Mdmx and suppressed p53 activity. Myc-induced tumorigenesis was accelerated in Peli1-null mice and associated with downregulation of p53 function. Clinical samples of human cutaneous melanoma had decreased Peli1 expression, which was associated with poor overall survival. Together, these results demonstrate that Peli1 acts as a critical factor for the Mdmx–p53 axis by modulating the subcellular localization and activity of Mdmx, thus revealing a novel mechanism of Mdmx deregulation in human cancers. Significance: Peli1-mediated regulation of Mdmx, a major inhibitor of p53, provides critical insight into activation of p53 function in human cancers. Cancer Res; 78(11); 2897–910. ©2018 AACR.
AbstractList Peli1-mediated regulation of Mdmx, a major inhibitor of p53, provides critical insight into activation of p53 function in human cancers.Mdm2 and Mdmx, both major repressors of p53 in human cancers, are predominantly localized to the nucleus and cytoplasm, respectively. The mechanism by which subcellular localization of Mdmx is regulated remains unclear. In this study, we identify the E3 ligase Peli1 as a major binding partner and regulator of Mdmx in human cells. Peli1 bound Mdmx in vitro and in vivo and promoted high levels of ubiquitination of Mdmx. Peli1-mediated ubiquitination was degradation-independent, promoting cytoplasmic localization of Mdmx, which in turn resulted in p53 activation. Consistent with this, knockdown or knockout Peli1 in human cancer cells induced nuclear localization of Mdmx and suppressed p53 activity. Myc-induced tumorigenesis was accelerated in Peli1-null mice and associated with downregulation of p53 function. Clinical samples of human cutaneous melanoma had decreased Peli1 expression, which was associated with poor overall survival. Together, these results demonstrate that Peli1 acts as a critical factor for the Mdmx–p53 axis by modulating the subcellular localization and activity of Mdmx, thus revealing a novel mechanism of Mdmx deregulation in human cancers.Significance: Peli1-mediated regulation of Mdmx, a major inhibitor of p53, provides critical insight into activation of p53 function in human cancers. Cancer Res; 78(11); 2897–910. ©2018 AACR.
Mdm2 and Mdmx, both major repressors of p53 in human cancers, are predominantly localized to the nucleus and cytoplasm, respectively. The mechanism by which subcellular localization of Mdmx is regulated remains unclear. In this study, we identify the E3 ligase Peli1 as a major binding partner and regulator of Mdmx in human cells. Peli1 bound Mdmx in vitro and in vivo and promoted high levels of ubiquitination of Mdmx. Peli1-mediated ubiquitination was degradation-independent, promoting cytoplasmic localization of Mdmx, which in turn resulted in p53 activation. Consistent with this, knockdown or knockout Peli1 in human cancer cells induced nuclear localization of Mdmx and suppressed p53 activity. Myc-induced tumorigenesis was accelerated in Peli1-null mice and associated with downregulation of p53 function. Clinical samples of human cutaneous melanoma had decreased Peli1 expression, which was associated with poor overall survival. Together, these results demonstrate that Peli1 acts as a critical factor for the Mdmx-p53 axis by modulating the subcellular localization and activity of Mdmx, thus revealing a novel mechanism of Mdmx deregulation in human cancers.Significance: Peli1-mediated regulation of Mdmx, a major inhibitor of p53, provides critical insight into activation of p53 function in human cancers. Cancer Res; 78(11); 2897-910. ©2018 AACR.Mdm2 and Mdmx, both major repressors of p53 in human cancers, are predominantly localized to the nucleus and cytoplasm, respectively. The mechanism by which subcellular localization of Mdmx is regulated remains unclear. In this study, we identify the E3 ligase Peli1 as a major binding partner and regulator of Mdmx in human cells. Peli1 bound Mdmx in vitro and in vivo and promoted high levels of ubiquitination of Mdmx. Peli1-mediated ubiquitination was degradation-independent, promoting cytoplasmic localization of Mdmx, which in turn resulted in p53 activation. Consistent with this, knockdown or knockout Peli1 in human cancer cells induced nuclear localization of Mdmx and suppressed p53 activity. Myc-induced tumorigenesis was accelerated in Peli1-null mice and associated with downregulation of p53 function. Clinical samples of human cutaneous melanoma had decreased Peli1 expression, which was associated with poor overall survival. Together, these results demonstrate that Peli1 acts as a critical factor for the Mdmx-p53 axis by modulating the subcellular localization and activity of Mdmx, thus revealing a novel mechanism of Mdmx deregulation in human cancers.Significance: Peli1-mediated regulation of Mdmx, a major inhibitor of p53, provides critical insight into activation of p53 function in human cancers. Cancer Res; 78(11); 2897-910. ©2018 AACR.
Mdm2 and Mdmx, both major repressors of p53 in human cancers, are predominantly localized to the nucleus and cytoplasm, respectively. The mechanism by which subcellular localization of Mdmx is regulated remains unclear. In this study, we identify the E3 ligase Peli1 as a major binding partner and regulator of Mdmx in human cells. Peli1 bound Mdmx in vitro and in vivo and promoted high levels of ubiquitination of Mdmx. Peli1-mediated ubiquitination was degradation-independent, promoting cytoplasmic localization of Mdmx which in turn resulted in p53 activation. Consistent with this, knockdown or knockout Peli1 in human cancer cells induced nuclear localization of Mdmx and suppressed p53 activity. Myc-induced tumorigenesis was accelerated in Peli1-null mice and associated with downregulation of p53 function. Clinical samples of human cutaneous melanoma had decreased Peli1 expression which was associated with poor overall survival. Together, these results demonstrate that Peli1 acts as a critical factor for the Mdmx-p53 axis by modulating the subcellular localization and activity of Mdmx, thus revealing a novel mechanism of Mdmx deregulation in human cancers.
Mdm2 and Mdmx, both major repressors of p53 in human cancers, are predominantly localized to the nucleus and cytoplasm, respectively. The mechanism by which subcellular localization of Mdmx is regulated remains unclear. In this study, we identify the E3 ligase Peli1 as a major binding partner and regulator of Mdmx in human cells. Peli1 bound Mdmx in vitro and in vivo and promoted high levels of ubiquitination of Mdmx. Peli1-mediated ubiquitination was degradation-independent, promoting cytoplasmic localization of Mdmx, which in turn resulted in p53 activation. Consistent with this, knockdown or knockout Peli1 in human cancer cells induced nuclear localization of Mdmx and suppressed p53 activity. Myc-induced tumorigenesis was accelerated in Peli1-null mice and associated with downregulation of p53 function. Clinical samples of human cutaneous melanoma had decreased Peli1 expression, which was associated with poor overall survival. Together, these results demonstrate that Peli1 acts as a critical factor for the Mdmx–p53 axis by modulating the subcellular localization and activity of Mdmx, thus revealing a novel mechanism of Mdmx deregulation in human cancers. Significance: Peli1-mediated regulation of Mdmx, a major inhibitor of p53, provides critical insight into activation of p53 function in human cancers. Cancer Res; 78(11); 2897–910. ©2018 AACR.
Mdm2 and Mdmx, both major repressors of p53 in human cancers, are predominantly localized to the nucleus and cytoplasm, respectively. The mechanism by which subcellular localization of Mdmx is regulated remains unclear. In this study, we identify the E3 ligase Peli1 as a major binding partner and regulator of Mdmx in human cells. Peli1 bound Mdmx and and promoted high levels of ubiquitination of Mdmx. Peli1-mediated ubiquitination was degradation-independent, promoting cytoplasmic localization of Mdmx, which in turn resulted in p53 activation. Consistent with this, knockdown or knockout Peli1 in human cancer cells induced nuclear localization of Mdmx and suppressed p53 activity. Myc-induced tumorigenesis was accelerated in Peli1-null mice and associated with downregulation of p53 function. Clinical samples of human cutaneous melanoma had decreased Peli1 expression, which was associated with poor overall survival. Together, these results demonstrate that Peli1 acts as a critical factor for the Mdmx-p53 axis by modulating the subcellular localization and activity of Mdmx, thus revealing a novel mechanism of Mdmx deregulation in human cancers. Peli1-mediated regulation of Mdmx, a major inhibitor of p53, provides critical insight into activation of p53 function in human cancers. .
Author Li, Dawei
Sun, Shao-Cong
Gu, Wei
Tavana, Omid
AuthorAffiliation 1 Institute for Cancer Genetics, Department of Pathology and Cell Biology, Herbert Irving Comprehensive Cancer Center, College of Physicians & Surgeons, Columbia University, HICCC Building, Rm#609, 1130 St. Nicholas Ave, New York, NY 10032, USA
2 Department of Immunology, The University of Texas MD Anderson Cancer Center, MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences, 7455 Fannin Street, Box 902, Houston, Texas 77030, USA
AuthorAffiliation_xml – name: 1 Institute for Cancer Genetics, Department of Pathology and Cell Biology, Herbert Irving Comprehensive Cancer Center, College of Physicians & Surgeons, Columbia University, HICCC Building, Rm#609, 1130 St. Nicholas Ave, New York, NY 10032, USA
– name: 2 Department of Immunology, The University of Texas MD Anderson Cancer Center, MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences, 7455 Fannin Street, Box 902, Houston, Texas 77030, USA
Author_xml – sequence: 1
  givenname: Dawei
  surname: Li
  fullname: Li, Dawei
– sequence: 2
  givenname: Omid
  surname: Tavana
  fullname: Tavana, Omid
– sequence: 3
  givenname: Shao-Cong
  surname: Sun
  fullname: Sun, Shao-Cong
– sequence: 4
  givenname: Wei
  surname: Gu
  fullname: Gu, Wei
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29523541$$D View this record in MEDLINE/PubMed
BookMark eNqFkVFLHDEUhYNYdNX-BMtAX3wZm5vJnSQUCstSa2FthbbPIZPJ1MjsxE4yUv31zahdrC99Csn9zuWcnAOyO4TBEXIM9BQA5TtKqSyRC3a6Wn4pQZQVVrBDFoCVLAXnuEsWW2afHMR4na8IFPfIPlPIKuSwIMtL13soLkI79Sa5WKQrV3ybGuv6Pr-MxTpY0_t7k3wYCjO0xdImf-vTXRG64qLd_D4irzrTR_f66TwkP84-fl-dl-uvnz6vluvS8kql0kBtalpL0XAKrLUIdcfqxrQKa8x-OoGN4rarrBAgjO2YkkxQ5ZirG0RXHZIPj3tvpmbjWuuGNJpe34x-Y8Y7HYzX_04Gf6V_hluNSvJaQV5w8rRgDL8mF5Pe-DjnNIMLU9Qs-1LAJKiMvn2BXodpHHK8THGBCqSQmXrz3NHWyt_fzQA-AnYMMY6u2yJA9dyinhvSc0M6t6hB6LnFrHv_Qmd9emggB_P9f9R_AMbQoOM
CitedBy_id crossref_primary_10_3389_fimmu_2022_728794
crossref_primary_10_1016_j_celrep_2023_112833
crossref_primary_10_3390_cells10102529
crossref_primary_10_1111_jcmm_14878
crossref_primary_10_1074_jbc_RA118_007150
crossref_primary_10_1021_acs_jmedchem_4c00913
crossref_primary_10_1093_jmcb_mjz007
crossref_primary_10_15252_embj_2020104410
crossref_primary_10_2147_BTT_S436629
crossref_primary_10_1016_j_isci_2022_105115
crossref_primary_10_1016_j_cellsig_2024_111194
crossref_primary_10_1016_j_pathol_2023_10_020
crossref_primary_10_1101_gad_347872_120
crossref_primary_10_1016_j_bbrc_2019_03_095
crossref_primary_10_1038_s41389_023_00457_3
Cites_doi 10.1016/j.molcel.2011.08.020
10.1093/jmcb/mjx001
10.1177/1947601912454733
10.1101/gad.13.20.2658
10.1016/j.molcel.2006.01.020
10.1158/1078-0432.CCR-05-0683
10.1002/humu.22524
10.1097/CCO.0000000000000033
10.1016/j.cell.2009.04.037
10.1074/jbc.M113.476606
10.1038/sj.onc.1208052
10.1042/BJ20071365
10.1074/jbc.M704558200
10.1242/jcs.03362
10.1074/jbc.M805658200
10.1111/imr.12298
10.1126/science.1091362
10.1093/jmcb/mjx004
10.1038/sj.emboj.7601465
10.1038/sj.emboj.7601469
10.1074/jbc.M212112200
10.1128/MCB.22.21.7562-7571.2002
10.1111/imr.12306
10.1073/pnas.95.14.8292
10.1002/humu.10185
10.1101/gad.12.15.2424
10.1101/gad.13.20.2670
10.1177/1947601912455324
10.1038/nri3599
10.1016/j.ccr.2009.05.008
10.1038/sj.onc.1210788
10.1016/j.canlet.2013.12.025
10.1016/j.cell.2005.03.037
10.1073/pnas.1102241108
10.1128/MCB.00555-06
10.1038/378203a0
10.1084/jem.167.2.353
10.1158/0008-5472.CAN-07-1313
10.1038/nm.2863
10.1016/j.cell.2009.04.050
10.1172/JCI75667
10.1002/jcb.21091
10.1038/ni.1777
10.1038/nrc3430
ContentType Journal Article
Copyright 2018 American Association for Cancer Research.
Copyright American Association for Cancer Research, Inc. Jun 1, 2018
Copyright_xml – notice: 2018 American Association for Cancer Research.
– notice: Copyright American Association for Cancer Research, Inc. Jun 1, 2018
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TM
7TO
7U9
8FD
FR3
H94
P64
RC3
7X8
5PM
DOI 10.1158/0008-5472.CAN-17-3531
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
Technology Research Database
Engineering Research Database
AIDS and Cancer Research Abstracts
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Genetics Abstracts
Virology and AIDS Abstracts
Oncogenes and Growth Factors Abstracts
Technology Research Database
Nucleic Acids Abstracts
AIDS and Cancer Research Abstracts
Immunology Abstracts
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList Genetics Abstracts
MEDLINE - Academic

CrossRef
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1538-7445
EndPage 2910
ExternalDocumentID PMC5984691
29523541
10_1158_0008_5472_CAN_17_3531
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: T32 CA009503
– fundername: NCI NIH HHS
  grantid: R01 CA190477
– fundername: NCI NIH HHS
  grantid: R01 CA193890
– fundername: NCI NIH HHS
  grantid: R01 CA085533
– fundername: NCI NIH HHS
  grantid: R01 CA216884
GroupedDBID ---
-ET
18M
29B
2WC
34G
39C
53G
5GY
5RE
5VS
6J9
AAFWJ
AAJMC
AAYXX
ABOCM
ACGFO
ACIWK
ACPRK
ACSVP
ADBBV
ADCOW
ADNWM
AENEX
AETEA
AFHIN
AFOSN
AFRAH
AFUMD
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BTFSW
CITATION
CS3
DIK
DU5
EBS
EJD
F5P
FRP
GX1
H13
IH2
KQ8
L7B
LSO
OK1
P0W
P2P
PQQKQ
RCR
RHI
RNS
SJN
TR2
W2D
W8F
WH7
WOQ
YKV
YZZ
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TM
7TO
7U9
8FD
FR3
H94
P64
RC3
7X8
5PM
ID FETCH-LOGICAL-c439t-a16a60687b4012dc516f26bad9565295f75b94cf3c7717acf2982709e2e6b55e3
ISSN 0008-5472
1538-7445
IngestDate Thu Aug 21 18:36:25 EDT 2025
Fri Jul 11 00:30:47 EDT 2025
Sun Jul 13 04:35:54 EDT 2025
Mon Jul 21 05:52:05 EDT 2025
Tue Jul 01 01:19:27 EDT 2025
Thu Apr 24 23:06:37 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Language English
License 2018 American Association for Cancer Research.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c439t-a16a60687b4012dc516f26bad9565295f75b94cf3c7717acf2982709e2e6b55e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://cancerres.aacrjournals.org/content/canres/78/11/2897.full.pdf
PMID 29523541
PQID 2047591878
PQPubID 105549
PageCount 14
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5984691
proquest_miscellaneous_2012912819
proquest_journals_2047591878
pubmed_primary_29523541
crossref_primary_10_1158_0008_5472_CAN_17_3531
crossref_citationtrail_10_1158_0008_5472_CAN_17_3531
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-06-01
PublicationDateYYYYMMDD 2018-06-01
PublicationDate_xml – month: 06
  year: 2018
  text: 2018-06-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Baltimore
PublicationTitle Cancer research (Chicago, Ill.)
PublicationTitleAlternate Cancer Res
PublicationYear 2018
Publisher American Association for Cancer Research, Inc
Publisher_xml – name: American Association for Cancer Research, Inc
References Wang (2022061706173794000_bib44) 2008; 27
Helton (2022061706173794000_bib3) 2007; 100
Chang (2022061706173794000_bib24) 2009; 10
Eischen (2022061706173794000_bib41) 1999; 13
Talantov (2022061706173794000_bib25) 2005; 11
Brooks (2022061706173794000_bib13) 2006; 21
Moynagh (2022061706173794000_bib29) 2014; 14
Zindy (2022061706173794000_bib39) 1998; 12
Kawai (2022061706173794000_bib15) 2007; 67
Kruse (2022061706173794000_bib1) 2009; 137
Butler (2022061706173794000_bib31) 2007; 282
Park (2022061706173794000_bib36) 2014; 124
Humphries (2022061706173794000_bib37) 2015; 266
Eischen (2022061706173794000_bib7) 2014; 35
Montes de Oca Luna (2022061706173794000_bib11) 1995; 378
Li (2022061706173794000_bib14) 2003; 302
Ordureau (2022061706173794000_bib30) 2008; 409
Gannon (2022061706173794000_bib5) 2012; 3
Chen (2022061706173794000_bib21) 2005; 121
Kruse (2022061706173794000_bib35) 2009; 284
Wang (2022061706173794000_bib33) 2009; 16
Harris (2022061706173794000_bib38) 1998; 167
Wade (2022061706173794000_bib8) 2013; 13
Li (2022061706173794000_bib22) 2011; 43
Poyurovsky (2022061706173794000_bib16) 2007; 26
Marine (2022061706173794000_bib12) 2007; 120
Uldrijan (2022061706173794000_bib17) 2007; 26
Li (2022061706173794000_bib34) 2002; 22
Jochemsen (2022061706173794000_bib20) 2014; 26
Vousden (2022061706173794000_bib2) 2009; 137
Chen (2022061706173794000_bib9) 2012; 3
Kamijo (2022061706173794000_bib40) 1998; 95
Pant (2022061706173794000_bib18) 2011; 108
Moyer (2022061706173794000_bib19) 2017
Medvedev (2022061706173794000_bib28) 2015; 266
Gembarska (2022061706173794000_bib26) 2012; 18
Eischen (2022061706173794000_bib43) 2004; 23
Liu (2022061706173794000_bib4) 2015; 356
Zhou (2022061706173794000_bib10) 2017; 9
Schmitt (2022061706173794000_bib42) 1999; 13
Varley (2022061706173794000_bib6) 2003; 21
Terzian (2022061706173794000_bib32) 2007; 27
Dai (2022061706173794000_bib23) 2013; 288
Jiang (2022061706173794000_bib27) 2003; 278
References_xml – volume: 43
  start-page: 1023
  year: 2011
  ident: 2022061706173794000_bib22
  article-title: A critical role for noncoding 5S rRNA in regulating Mdmx stability
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2011.08.020
– volume: 9
  start-page: 62
  year: 2017
  ident: 2022061706173794000_bib10
  article-title: Negative auto-regulators trap p53 in their web
  publication-title: J Mol Cell Biol
  doi: 10.1093/jmcb/mjx001
– volume: 3
  start-page: 274
  year: 2012
  ident: 2022061706173794000_bib9
  article-title: The roles of MDM2 and MDMX phosphorylation in stress signaling to p53
  publication-title: Genes Cancer
  doi: 10.1177/1947601912454733
– volume: 13
  start-page: 2658
  year: 1999
  ident: 2022061706173794000_bib41
  article-title: Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis
  publication-title: Genes Dev
  doi: 10.1101/gad.13.20.2658
– volume: 21
  start-page: 307
  year: 2006
  ident: 2022061706173794000_bib13
  article-title: p53 ubiquitination: Mdm2 and beyond
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2006.01.020
– volume: 11
  start-page: 7234
  year: 2005
  ident: 2022061706173794000_bib25
  article-title: Novel genes associated with malignant melanoma but not benign melanocytic lesions
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-05-0683
– volume: 35
  start-page: 728
  year: 2014
  ident: 2022061706173794000_bib7
  article-title: The Mdm network and its regulation of p53 activities: a rheostat of cancer risk
  publication-title: Hum Mutat
  doi: 10.1002/humu.22524
– volume: 26
  start-page: 114
  year: 2014
  ident: 2022061706173794000_bib20
  article-title: Reactivation of p53 as therapeutic intervention for malignant melanoma
  publication-title: Curr Opin Oncol
  doi: 10.1097/CCO.0000000000000033
– volume: 137
  start-page: 413
  year: 2009
  ident: 2022061706173794000_bib2
  article-title: Blinded by the light: the growing complexity of p53
  publication-title: Cell
  doi: 10.1016/j.cell.2009.04.037
– volume: 288
  start-page: 19581
  year: 2013
  ident: 2022061706173794000_bib23
  article-title: Negative regulation of the acetyltransferase TIP60-p53 interplay by UHRF1 (ubiquitin-like with PHD and RING finger domains 1)
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M113.476606
– volume: 23
  start-page: 8931
  year: 2004
  ident: 2022061706173794000_bib43
  article-title: Loss of one allele of ARF rescues Mdm2 haploinsufficiency effects on apoptosis and lymphoma development
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1208052
– volume: 409
  start-page: 43
  year: 2008
  ident: 2022061706173794000_bib30
  article-title: The IRAK-catalysed activation of the E3 ligase function of Pellino isoforms induces the Lys63-linked polyubiquitination of IRAK1
  publication-title: Biochem J
  doi: 10.1042/BJ20071365
– volume: 282
  start-page: 29729
  year: 2007
  ident: 2022061706173794000_bib31
  article-title: Kinase-active interleukin-1 receptor-associated kinases promote polyubiquitination and degradation of the Pellino family: direct evidence for PELLINO proteins being ubiquitin-protein isopeptide ligases
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M704558200
– volume: 120
  start-page: 371
  year: 2007
  ident: 2022061706173794000_bib12
  article-title: MDMX: from bench to bedside
  publication-title: J Cell Sci
  doi: 10.1242/jcs.03362
– volume: 284
  start-page: 3250
  year: 2009
  ident: 2022061706173794000_bib35
  article-title: MSL2 promotes Mdm2-independent cytoplasmic localization of p53
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M805658200
– volume: 266
  start-page: 109
  year: 2015
  ident: 2022061706173794000_bib28
  article-title: E3 ubiquitin ligases Pellinos as regulators of pattern recognition receptor signaling and immune responses
  publication-title: Immunol Rev
  doi: 10.1111/imr.12298
– volume: 302
  start-page: 1972
  year: 2003
  ident: 2022061706173794000_bib14
  article-title: Mono- versus polyubiquitination: differential control of p53 fate by Mdm2
  publication-title: Science
  doi: 10.1126/science.1091362
– year: 2017
  ident: 2022061706173794000_bib19
  article-title: Mdm proteins: critical regulators of embry ogenesis and homeostasis
  publication-title: J Mol Cell Biol
  doi: 10.1093/jmcb/mjx004
– volume: 26
  start-page: 90
  year: 2007
  ident: 2022061706173794000_bib16
  article-title: The Mdm2 RING domain C-terminus is required for supramolecular assembly and ubiquitin ligase activity
  publication-title: EMBO J
  doi: 10.1038/sj.emboj.7601465
– volume: 26
  start-page: 102
  year: 2007
  ident: 2022061706173794000_bib17
  article-title: An essential function of the extreme C-terminus of MDM2 can be provided by MDMX
  publication-title: EMBO J
  doi: 10.1038/sj.emboj.7601469
– volume: 278
  start-page: 10952
  year: 2003
  ident: 2022061706173794000_bib27
  article-title: Pellino 1 is required for interleukin-1 (IL-1)-mediated signaling through its interaction with the IL-1 receptor-associated kinase 4 (IRAK4)-IRAK-tumor necrosis factor receptor-associated factor 6 (TRAF6) complex
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M212112200
– volume: 22
  start-page: 7562
  year: 2002
  ident: 2022061706173794000_bib34
  article-title: DNA damage induces MDMX nuclear translocation by p53-dependent and -independent mechanisms
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.22.21.7562-7571.2002
– volume: 266
  start-page: 93
  year: 2015
  ident: 2022061706173794000_bib37
  article-title: Molecular and physiological roles of Pellino E3 ubiquitin ligases in immunity
  publication-title: Immunol Rev
  doi: 10.1111/imr.12306
– volume: 95
  start-page: 8292
  year: 1998
  ident: 2022061706173794000_bib40
  article-title: Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.95.14.8292
– volume: 21
  start-page: 313
  year: 2003
  ident: 2022061706173794000_bib6
  article-title: Germline TP53 mutations and Li-Fraumeni syndrome
  publication-title: Hum Mutat
  doi: 10.1002/humu.10185
– volume: 12
  start-page: 2424
  year: 1998
  ident: 2022061706173794000_bib39
  article-title: Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
  publication-title: Genes Dev
  doi: 10.1101/gad.12.15.2424
– volume: 13
  start-page: 2670
  year: 1999
  ident: 2022061706173794000_bib42
  article-title: INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53
  publication-title: Genes Dev
  doi: 10.1101/gad.13.20.2670
– volume: 3
  start-page: 209
  year: 2012
  ident: 2022061706173794000_bib5
  article-title: Using mouse models to explore MDM-p53 signaling in development, cell growth, and tumorigenesis
  publication-title: Genes Cancer
  doi: 10.1177/1947601912455324
– volume: 14
  start-page: 122
  year: 2014
  ident: 2022061706173794000_bib29
  article-title: The roles of Pellino E3 ubiquitin ligases in immunity
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri3599
– volume: 16
  start-page: 33
  year: 2009
  ident: 2022061706173794000_bib33
  article-title: Increased radioresistance and accelerated B cell lymphomas in mice with Mdmx mutations that prevent modifications by DNA-damage-activated kinases
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2009.05.008
– volume: 27
  start-page: 1590
  year: 2008
  ident: 2022061706173794000_bib44
  article-title: Elevated Mdm2 expression induces chromosomal instability and confers a survival and growth advantage to B cells
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1210788
– volume: 356
  start-page: 197
  year: 2015
  ident: 2022061706173794000_bib4
  article-title: Tumor suppressor p53 and its mutants in cancer metabolism
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2013.12.025
– volume: 121
  start-page: 1071
  year: 2005
  ident: 2022061706173794000_bib21
  article-title: ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor
  publication-title: Cell
  doi: 10.1016/j.cell.2005.03.037
– volume: 108
  start-page: 11995
  year: 2011
  ident: 2022061706173794000_bib18
  article-title: Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stability
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1102241108
– volume: 27
  start-page: 5479
  year: 2007
  ident: 2022061706173794000_bib32
  article-title: Haploinsufficiency of Mdm2 and Mdm4 in tumorigenesis and development
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.00555-06
– volume: 378
  start-page: 203
  year: 1995
  ident: 2022061706173794000_bib11
  article-title: Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53
  publication-title: Nature
  doi: 10.1038/378203a0
– volume: 167
  start-page: 353
  year: 1998
  ident: 2022061706173794000_bib38
  article-title: The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells
  publication-title: J Exp Med
  doi: 10.1084/jem.167.2.353
– volume: 67
  start-page: 6026
  year: 2007
  ident: 2022061706173794000_bib15
  article-title: RING domain-mediated interaction is a requirement for MDM2′s E3 ligase activity
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-07-1313
– volume: 18
  start-page: 1239
  year: 2012
  ident: 2022061706173794000_bib26
  article-title: MDM4 is a key therapeutic target in cutaneous melanoma
  publication-title: Nat Med
  doi: 10.1038/nm.2863
– volume: 137
  start-page: 609
  year: 2009
  ident: 2022061706173794000_bib1
  article-title: Modes of p53 regulation
  publication-title: Cell
  doi: 10.1016/j.cell.2009.04.050
– volume: 124
  start-page: 4976
  year: 2014
  ident: 2022061706173794000_bib36
  article-title: Pellino 1 promotes lymphomagenesis by deregulating BCL6 polyubiquitination
  publication-title: J Clin Invest
  doi: 10.1172/JCI75667
– volume: 100
  start-page: 883
  year: 2007
  ident: 2022061706173794000_bib3
  article-title: p53 modulation of the DNA damage response
  publication-title: J Cell Biochem
  doi: 10.1002/jcb.21091
– volume: 10
  start-page: 1089
  year: 2009
  ident: 2022061706173794000_bib24
  article-title: Peli1 facilitates TRIF-dependent Toll-like receptor signaling and proinflammatory cytokine production
  publication-title: Nat Immunol
  doi: 10.1038/ni.1777
– volume: 13
  start-page: 83
  year: 2013
  ident: 2022061706173794000_bib8
  article-title: MDM2, MDMX and p53 in oncogenesis and cancer therapy
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc3430
SSID ssj0005105
Score 2.3620987
Snippet Mdm2 and Mdmx, both major repressors of p53 in human cancers, are predominantly localized to the nucleus and cytoplasm, respectively. The mechanism by which...
Peli1-mediated regulation of Mdmx, a major inhibitor of p53, provides critical insight into activation of p53 function in human cancers.Mdm2 and Mdmx, both...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 2897
SubjectTerms Animals
Cancer
Cell Cycle Proteins
Cell Line
Cell Line, Tumor
Cytoplasm
Cytoplasm - metabolism
HEK293 Cells
Humans
Localization
MDM2 protein
Melanoma
Melanoma - metabolism
Melanoma, Cutaneous Malignant
Mice
Myc protein
Nuclear Proteins - metabolism
Nuclei
p53 Protein
Proto-Oncogene Proteins - metabolism
Proto-Oncogene Proteins c-mdm2 - metabolism
Repressors
Rodents
Skin Neoplasms - metabolism
Tumor Suppressor Protein p53 - metabolism
Tumorigenesis
Ubiquitin-protein ligase
Ubiquitin-Protein Ligases - metabolism
Ubiquitination
Ubiquitination - physiology
Title Peli1 Modulates the Subcellular Localization and Activity of Mdmx
URI https://www.ncbi.nlm.nih.gov/pubmed/29523541
https://www.proquest.com/docview/2047591878
https://www.proquest.com/docview/2012912819
https://pubmed.ncbi.nlm.nih.gov/PMC5984691
Volume 78
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKIiEuiPcWFhQkbquUOrFj51hVu6yg2wXRSr1FsWNrK3VTtLQC8RP41cw4zqN0xesSRXk5mvk8nrE_zxDyWgrLbaFtmPKiCJniPJTKilAom6QF46lxaRfPp8nZnL1b8EWv96PDWtpu1EB_v3Ffyf9oFa6BXnGX7D9otvkoXIBz0C8cQcNw_CsdfzCrJcVyZliDC3M1gM7BEuBkvGOXTnCg8hst3SrBSPtiEUh8Ka6-dV3TMer_-thn_7l0y7sVT8PZkdVq0Jk1mPj96V_Nso39sT7z8cVVzZF3ddnX4diTfj9tGxy-3Tpqn3_XzzlQ2XKjOjR_sD8dCDlWpP_TmjS4R-dEjyPkrCrWMzCtyRWsSipZ22Qhu9ijXQsrKz6vH62jtGLF7o8EXFbUyarBwXg0DWFAjrkfdHYyb08vstP5ZJLNThazW-R2BCEH2sz3H9vM89zTYesP-t1g0MybGxvZ9XP2gpdfObgdp2Z2n9zz0UgwqqD1gPRM-ZDcOfd8i0dk5BAWNAgLAGFBB2FBF2EBICyoERasbYAIe0zmpyez8Vnoi26EGnzTTZjTJIegVgoFkXdUaE4TGyUqLyCQxkVhK7hKmbaxFoKKXNsolZEYpiYyCfR0Ez8hB-W6NIck0LHKqcyF1lowwyJl5TAdFkqwPGe0KPqE1SLKtM9Ij4VRVpmLTLlEZoTMULIZSDajIkPJ9smgee1zlZLlTy8c1fLPfO_9kkVDzHRJpZB98qq5DbYVJZiXZr3FZ8AbdkvNffK0UlfTIogiijmDj4sdRTYPYN723Tvl8tLlb-cpOP0pffb733pO7rZd74gcbK635gU4wBv10iHzJ5Mpq1s
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Peli1+Modulates+the+Subcellular+Localization+and+Activity+of+Mdmx&rft.jtitle=Cancer+research+%28Chicago%2C+Ill.%29&rft.au=Li%2C+Dawei&rft.au=Tavana+Omid&rft.au=Shao-Cong%2C+Sun&rft.au=Gu%2C+Wei&rft.date=2018-06-01&rft.pub=American+Association+for+Cancer+Research%2C+Inc&rft.issn=0008-5472&rft.eissn=1538-7445&rft.volume=78&rft.issue=11&rft.spage=2897&rft.epage=2910&rft_id=info:doi/10.1158%2F0008-5472.CAN-17-3531&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0008-5472&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0008-5472&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0008-5472&client=summon